Untargeted metabolomics on control and compound-treated STHdhQ111 cells and control STHdhQ7 cells
Ontology highlight
ABSTRACT: Cells expressing mutant huntingtin were treated in triplicate with serum-free DMEM with vehicle (Q111SST) or serum-free DMEM with one of 14 protective compounds for 24 hours. Wild type cells were also treated with serum-free DMEM with vehicle (Q7SST) as an additional control for 24 hours. We examined the compounds' metabolomic effects on the cells using untargeted mass spectrometry, which measured lipids and polar metabolites.
ORGANISM(S): Mouse Mus Musculus
TISSUE(S): Cultured Cells
DISEASE(S): Huntingtons Disease
SUBMITTER: Natasha Patel-Murray
PROVIDER: ST001186 | MetabolomicsWorkbench | Fri May 24 00:00:00 BST 2019
REPOSITORIES: MetabolomicsWorkbench
ACCESS DATA